Recent study showed that glycyrrhizic acid alleviated doxorubicin-induced glomerular sclerosis by inhibiting the TGF-β1 signaling pathway in rats (Table 1) (Huang et al., 2009). The gene discussed is TGFB1; the disease is glomerulosclerosis.